Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 759-788
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Mitochondrial alterations in fatty liver diseases
Bernard Fromenty, Michael Roden
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 415-429
Open Access | Times Cited: 189
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation
Paola Dongiovanni, Marica Meroni, Sara Casati, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 62
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care
Juan Patricio Nogueira, Kenneth Cusi
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 20-28
Open Access | Times Cited: 39
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism (2024) Vol. 160, pp. 156004-156004
Closed Access | Times Cited: 16
Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD)
Christina‐Maria Flessa, Ioannis Kyrou, Narjes Nasiri‐Ansari, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1585-1606
Closed Access | Times Cited: 46
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
The fatty liver disease–causing protein PNPLA3-I148M alters lipid droplet–Golgi dynamics
David J. Sherman, Lei Liu, Jennifer L. Mamrosh, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 18
Open Access | Times Cited: 11
Genetics Is of the Essence to Face NAFLD
Marica Meroni, Miriam Longo, Giada Tria, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1359-1359
Open Access | Times Cited: 49
Towards precision medicine in non-alcoholic fatty liver disease
Sven Francque
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 885-899
Closed Access | Times Cited: 15
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Jing Liu, Henry N. Ginsberg, Gissette Reyes‐Soffer
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 157-161
Open Access | Times Cited: 6
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
Ma Yang, Jinguo Wang, Wenping Xiao, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
Monika Bhardwaj, Papiya Mitra Mazumder
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Newly identified single-nucleotide polymorphism associated with the transition from nonalcoholic fatty liver disease to liver fibrosis: results from a nested case-control study in the UK biobank
Yitong Ling, Yu Xuan Yang, Yan Chun Chen, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD
Ke Mi, Tingdan Ye, Lin Zhu, et al.
Gastroenterology report (2025) Vol. 13
Open Access
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Fanglin Ma, Miriam Longo, Marica Meroni, et al.
Cell Metabolism (2025)
Closed Access
Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms
Gregory R. Steinberg, Celina M. Valvano, William De Nardo, et al.
Journal of Hepatology (2025)
Open Access
Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, R. C. Siriwardana, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Miriam Longo, Erika Paolini, Marica Meroni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 36
The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics
Navya Malladi, Md Jahangir Alam, Subir Kumar Maulik, et al.
Prostaglandins & Other Lipid Mediators (2023) Vol. 169, pp. 106766-106766
Closed Access | Times Cited: 14
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2521-2521
Open Access | Times Cited: 13
The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review
Charles Leahy, Nicholas J. Osborne, Leticia Shirota, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116241-116241
Closed Access | Times Cited: 4
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
Salvatore Petta, Angelo Armandi, Elisabetta Bugianesi
Liver International (2024)
Open Access | Times Cited: 4
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
Jingjing Ding, Huaizheng Liu, Xiaoxun Zhang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 4
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top